| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.0042 | 1 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |